Clinical Results Show Blood Pressure Reduction Using Paradise Ultrasound System
What happened
Felix Mahfoud presented findings from the Global Paradise System Registry, which tracked 276 patients treated across nine European countries. The Paradise uRDN system is an ultrasound-based technology designed to lower blood pressure by denervating sympathetic nerves around renal arteries. At 12 months, patients showed an average reduction of 19.5 mmHg in office systolic blood pressure, with favorable safety results observed.
From manilatimes.net
Why it matters
The results provide real-world evidence supporting the safety and effectiveness of the Paradise uRDN system for treating hypertension. This clinical validation is relevant to the market for medical devices and renal denervation technology.
Recor Medical is utilizing the Paradise uRDN system, which was recently recognized as an innovation by Time.
From manilatimes.net
Who's involved
- Felix MahfoudResearcher who presented the clinical results using the Paradise system
- ParadiseThe novel ultrasound-based technology used to treat hypertension
Who could feel it
Possible knock-on effectsThese are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.
- Felix MahfoudSpeculative
Felix Mahfoud could see increased research funding or contracts related to the Paradise system's adoption.